Clinical Applications of Liquid Chromatography-Mass Spectrometry (LC-MS) for Metabolites, Toxicology and Therapeutic Drug Analysis

Asmaa Hussein Obaid (1)
(1) University of Thi-Qar, College of Science, Iraq. e-mail: asmaahussien199600@gmail.com , Iraq

Abstract

As a potent quantitative and qualitative analytical technique, LC-MS/MS is useful in many fields, including toxicology, endocrinology, paediatrics, microbiology, therapeutic drug monitoring (TDM), and the new field of proteomics. It is also possible to use LC-MS/MS to analyse biological materials, such as blood and urine. The recent founding of the Mass Spectrometry and Separation Sciences Division of the AACC and the increasing number of LC-MS/MS papers and conferences demonstrate a growing interest in the clinical use of mass spectrometry. Analysing complex combinations is the basic idea behind tandem mass spectrometry, which involves connecting several mass spectrometers in a chain.


This method employs a collision cell sandwiched between two sequentially organised mass filters. You can use the filters in either a static or scanning mode to choose a specific mass-to-charge (m/z) ratio or m/z range. Precursor ions, which are bigger, smash with gas molecules in the collision cell, causing them to split into product ions, which are smaller. One of several possible scan modes for a tandem mass spectrometer is determined by the therapeutic application. Toxicology is an interdisciplinary science that seeks to clarify the quantitative and qualitative connections between poisonous substances and the physiological and behavioural impacts they have on living organisms. There are a number of important and prominent aspects of toxicology, including the study of poisons' mechanisms of action and the creation of treatments and therapies for the associated harmful effects. As a result of these efforts, mass spectrometry (MS), an analytical technology with a wide variety of applications, has developed into a strong tool that is applied in the toxicological analysis of medications, poisons, and the metabolites of both. Even now, MS finds use in every subfield of toxicology, from environmental toxicology and forensic toxicology to clinical toxicology. Nowadays, toxicology labs rely on mass spectrometry and its hyphenated applications, which include GC-MS, LC-MS, ICP-MS, and tandem mass spectrometry / MS and MSn. Despite the widespread use of many analytical tools in these domains, this remains the case. The hyphenated MS technology and their toxicological applications will be the focus of this review.

Full text article

Generated from XML file

References

Viette, V., Hochstrasser, D., and Fathi, M. (2012) LC-MS (/MS) in Clinical Toxicology Screening Methods, Chimia 66, 339-342.

Goulle, J. P., Saussereau, E., Mahieu, L., and Guerbet, M. (2014) Current role of ICP-MS in clinical toxicology and forensic toxicology: a metallic profile, Bioanalysis 6, 2245-2259.

Shannon, M., Cox, M. N., and Baum, C. R. (1998) Toxicology reviews: Immunoassay in detecting drugs of abuse, Pediatr Emerg Care 14, 372-375. 7. Holstege, C. P., and Borek, H. A. (2012) Toxidromes, Crit Care Clin 28, 479

Pappas, A. A., Massoll, N. A., and Cannon, D. J. (1999) Toxicology: Past, present, and future, Ann Clin Lab Sci 29, 253-262.

Ettre, L. S., and Sakodynskii, K. I. (1993) Tswett,M.S. And the Discovery of Chromatography .2. Completion of the Development of Chromatography (1903-1910), Chromatographia 35, 329-338.

Pippenger, C. E. (1979) Therapeutic drug monitoring: an overview, Ther Drug Monit 1, 3-9. Wen, B., and Zhu, M. S. (2015) Applications of mass spectrometry in drug metabolism: 50 years of progress, Drug Metab Rev 47, 71-87.

Glish, G. L., and Vachet, R. W. (2003) The basics of mass spectrometry in the twenty-first century, Nat Rev Drug Discov 2, 140-150.

Grebe, S. K. G., and Singh, R. J. (2011) LC-MS/MS in the Clinical Laboratory – Where to From Here?, Clin. Biochem. Rev. 32, 5-31.

Garg, U., and Zhang, Y. V. (2016) Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology, Methods Mol Biol 1383, 1-10.

Maurer, H. H., and Meyer, M. R. (2016) High-resolution mass spectrometry in toxicology: current status and future perspectives, Arch Toxicol 90, 2161-2172.

Hart-Smith, G., and Blanksby, S. J. (2012) Mass analysis, in Mass Spectrometry in Polymer Chemistry (eds C. Barner-Kowollik, T. Gruendling, J. Falkenhagen and S. Weidner), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.

Nair, H., Woo, F., Hoofnagle, A. N., and Baird, G. S. (2013) Why GCMS Remains an Invaluable Tool in a Toxicology Lab: A Novel Approach to Clinical Validation of a High Sensitive GCMS Platform for Urine Drug Screening, American journal of clinical pathology 140, 431-431.

Ojanpera, I., Kolmonen, M., and Pelander, A. (2012) Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control, Anal Bioanal Chem 403, 1203-1220.

Becker, J. O., and Hoofnagle, A. N. (2012) Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS, Bioanalysis 4, 281-290.

Strathmann, F. G., and Hoofnagle, A. N. (2011) Current and future applications of mass spectrometry to the clinical laboratory, American journal of clinical pathology 136, 609-616.

Jannetto, P. J., and Fitzerald, R. L. (2016) Effective Use of Mass Spectrometry in the Clinical Laboratory, Clin Chem 62, 92-98.

Adaway, J. E., Keevil, B. G., and Owen, L. J. (2015) Liquid chromatography tandem mass spectrometry in the clinical laboratory, Ann Clin Biochem 52, 18-38.

Lynch, K. L., Breaud, A. R., Vandenberghe, H., Wu, A. H. B., and Clarke, W. (2010) Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening, Clin Chim Acta 411, 1474-1481.

Senda N, Kohta K, Takahashi T, Shizukuishi K, Mimura T,Fujita T, Nakayama M. 1995. A highly sensitive method toquantify triazolam and its metabolites with liquid chro-matography±mass spectrometry. Biomed Chromatogr9:48±51.

Joyce JR, Ardrey RE, Lewis AS. 1985. Thermospray LC/MSapplied to the analysis of complex mixtures of non-polarmaterials. Biomed Mass Spectrom 12:588±592.

Heeremans CEM, Stijen AM, Van der Hoeven RAM, NiessenWMA, Danhof M, Van der Greef J. 1991. Liquidchromatography-thermospray mass spectrometry for iden-ti®cation of a heptabarbital metabolite and sample work-upartifacts. J Chromatogr 554:205±214.

Henion JD, Thomson BA, Dawson PH. 1982. Determination ofsulfa drugs in biological ¯uids by liquid chromatography/mass spectrometry/mass spectrometry. Anal Chem 54:451±456.

Hieda Y, Kashimura S, Hara K, Kageura M. 1995. Higlysensitive and rapid determination of theophylline, theo-bromine and caffeine in human plasma and urine bygradient capillary high-performance liquid chromatography-frit-fast atom bombardment mass spectrometry. JChromatogr 667:241±246.

Higton DM, Oxford JM. 1995. Mass spectrometry: pharmaceutical sciences. Appl Spectroscopy Rev 30:81±118.Hill RE. 1990. The widening horizons of bioanalytical mass-spectrometry. Clin Chim Acta 194:1±18.

Jitsufuchi N, Kudo K, Tokunaga H, Imamura T. 1997. Selective determination of sultopride in human plasma using high-performance liquid chromatography with ultraviolet detection and particle beam mass spectrometry. J. Chromatogr.690, 153±159.

Jeanville PM, EstapeÂES, Needham SR, Cole MJ. 2000. Rapidcon ®rmation/quantitation of cocaine and benzoylecgoninein urine utilizing high performance liquid chromatography and tandem mass spectrometry. J Am Soc Mass Spectrom11:257±263.

Katagi M, Nishikawa M, Tatsuno M, Miyazawa T, TsuchihashiH, Suzuki A, Shirota O. 1998. Direct analysis of methamphetamine and amphetamine enantiomers inhuman urine by semi-microcolumn HPLC electrospray ionization mass spectrometry. Jpn J Toxicol EnvironHealth 44:107±115

Sato K, Moore CM, Kobayashi K, Mizuno Y, Katsumata Y.1992b. Analyses of drugs by capillary high performanceliquid chromatography/fast atom bombardment-mass spec-trometry, Part 2 Identi®cation of chlordiazepoxide and itsmetabolites in human serum. Jpn J Forensic Toxicol10:23

Singh G, Arora V, Fenn PT, Mets B, Blair I. 1999. A validatedstable isotope dilution liquid chromatography tandemmass spectrometry assay for the trace analysis of cocaineand its major metabolites in plasma. Anal Chem 71:2021±2027.

Authors

Asmaa Hussein Obaid
Obaid, A. H. . (2024). Clinical Applications of Liquid Chromatography-Mass Spectrometry (LC-MS) for Metabolites, Toxicology and Therapeutic Drug Analysis. Journal of Current Medical Research and Opinion, 7(02), 2115–2122. https://doi.org/10.52845/CMRO/2024/7-2-8

Article Details